AI Stock Finder
Loading...
Skip to main content
Sign in Sign up
Model output · Signal date Oct. 14, 2026

Daily Signals

2482 companies scored · 2026-10-14 run in progress: 3985 of ~5379 signals so far · Alpha · vs marketSwitch to Total · 30D 90D

Create a free account Unlock all ratings
Signal date 2026-10-14 Cut-offs from the 2026-10-13 run
Companies scored 2482 IC ≥ 0 · market cap ≥ $100M
Median forecast +0.26% Alpha · 90D
Long–short spread +3.95% Strong Buy minus Strong Sell, mean
Median IC 0.29 Spearman · 90D
Rating changes ▲ 55 ▼ 59 vs the previous run
Cross-section

Distribution of the day's forecasts

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

-2.6% 0 +2.5%
Signals · All

287 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

# Ticker Sector IC Mkt cap Rating 30D 90D Δ
51 SRRKScholar Rock Holding Corp Life Sciences 0.22 $4.9B Unlock rating and forecasts
52 TVTXTravere Therapeutics, Inc. Life Sciences 0.32 $4.9B Unlock rating and forecasts
53 COGTCogent Biosciences, Inc. Life Sciences 0.32 $4.9B Unlock rating and forecasts
54 AMRNAMARIN CORP PLC\UK Life Sciences 0.14 $4.9B Neutral +0.37% +0.29% ·
55 CRSPCRISPR Therapeutics AG Life Sciences 0.12 $4.8B Unlock rating and forecasts
56 GPCRStructure Therapeutics Inc. Life Sciences 0.06 $4.8B Unlock rating and forecasts
57 DFTXDefinium Therapeutics, Inc. Life Sciences 0.29 $4.6B Neutral +0.37% +0.17% ·
58 DNTHDianthus Therapeutics, Inc. /DE/ Life Sciences 0.48 $4.3B Unlock rating and forecasts
59 INDVIndivior Pharmaceuticals, Inc. Life Sciences 0.35 $4.2B Unlock rating and forecasts
60 ADPTAdaptive Biotechnologies Corp Life Sciences 0.08 $4.0B Unlock rating and forecasts
61 EWTXEdgewise Therapeutics, Inc. Life Sciences 0.23 $3.9B Unlock rating and forecasts
62 ABCLAbCellera Biologics Inc. Life Sciences 0.51 $3.9B Unlock rating and forecasts
63 RLAYRelay Therapeutics, Inc. Life Sciences 0.45 $3.8B Unlock rating and forecasts
64 TNGXTango Therapeutics, Inc. Life Sciences 0.35 $3.7B Unlock rating and forecasts
65 TLXTelix Pharmaceuticals Ltd Life Sciences 0.06 $3.7B Unlock rating and forecasts
66 OGNOrganon & Co. Life Sciences 0.50 $3.6B Unlock rating and forecasts
67 XENEXenon Pharmaceuticals Inc. Life Sciences 0.44 $3.3B Unlock rating and forecasts
68 IDYAIDEAYA Biosciences, Inc. Life Sciences 0.17 $3.3B Unlock rating and forecasts
69 ARQTArcutis Biotherapeutics, Inc. Life Sciences 0.17 $3.3B Unlock rating and forecasts
70 ACADACADIA PHARMACEUTICALS INC Life Sciences 0.51 $3.2B Unlock rating and forecasts
71 VKTXViking Therapeutics, Inc. Life Sciences 0.02 $3.1B Unlock rating and forecasts
72 TARSTarsus Pharmaceuticals, Inc. Life Sciences 0.04 $3.1B Unlock rating and forecasts
73 AMLXAmylyx Pharmaceuticals, Inc. Life Sciences 0.20 $3.0B Unlock rating and forecasts
74 DNLIDenali Therapeutics Inc. Life Sciences 0.16 $2.9B Unlock rating and forecasts
75 ELVNEnliven Therapeutics, Inc. Life Sciences 0.40 $2.9B Neutral +0.37% +0.49% ·
76 RCUSArcus Biosciences, Inc. Life Sciences 0.32 $2.9B Unlock rating and forecasts
77 DYNDyne Therapeutics, Inc. Life Sciences 0.14 $2.9B Unlock rating and forecasts
78 RADXRadiopharm Theranostics Ltd Life Sciences 0.23 $2.8B Unlock rating and forecasts
79 PGENPRECIGEN, INC. Life Sciences 0.43 $2.7B Unlock rating and forecasts
80 DBVTDBV Technologies S.A. Life Sciences 0.18 $2.7B Unlock rating and forecasts
81 NEOGNEOGEN CORP Life Sciences 0.30 $2.6B Unlock rating and forecasts
82 BEAMBeam Therapeutics Inc. Life Sciences 0.26 $2.5B Unlock rating and forecasts
83 LQDALiquidia Corp Life Sciences 0.23 $2.4B Unlock rating and forecasts
84 ADMAADMA BIOLOGICS, INC. Life Sciences 0.51 $2.3B Unlock rating and forecasts
85 PBHPrestige Consumer Healthcare Inc. Life Sciences 0.36 $2.3B Unlock rating and forecasts
86 NRIXNurix Therapeutics, Inc. Life Sciences 0.23 $2.3B Neutral -0.05% -0.43% ·
87 CLDXCelldex Therapeutics, Inc. Life Sciences 0.24 $2.2B Unlock rating and forecasts
88 BHCBausch Health Companies Inc. Life Sciences 0.37 $2.2B Unlock rating and forecasts
89 AUPHAurinia Pharmaceuticals Inc. Life Sciences 0.16 $2.2B Unlock rating and forecasts
90 HRMYHarmony Biosciences Holdings, Inc. Life Sciences 0.31 $2.2B Unlock rating and forecasts
91 PRGOPERRIGO Co plc Life Sciences 0.56 $2.1B Neutral +0.23% +0.20% ·
92 NVAXNOVAVAX INC Life Sciences 0.32 $2.1B Unlock rating and forecasts
93 VRDNViridian Therapeutics, Inc.\DE Life Sciences 0.51 $2.1B Unlock rating and forecasts
94 VCELVericel Corp Life Sciences 0.27 $2.1B Neutral -0.10% +0.45% ·
95 BCRXBIOCRYST PHARMACEUTICALS INC Life Sciences 0.59 $2.1B Unlock rating and forecasts
96 IMNMImmunome Inc. Life Sciences 0.11 $2.0B Unlock rating and forecasts
97 TRLVTrulieve Cannabis Corp. Life Sciences 0.06 $1.9B Neutral +0.23% +0.46% ·
98 SDGRSchrodinger, Inc. Life Sciences 0.46 $1.9B Unlock rating and forecasts
99 VERAVera Therapeutics, Inc. Life Sciences 0.10 $1.9B Unlock rating and forecasts
100 LKFTLakefront Biotherapeutics NV Life Sciences 0.33 $1.9B Unlock rating and forecasts
51–100 of 287 Previous Next
Breadth

By sector

Median 90D forecast per sector. Click to filter.

Life Sciences287 +0.9% Finance or Crypto Assets36 +0.6% Finance351 +0.4% Technology337 +0.4% Trade & Services324 +0.3% Manufacturing422 +0.1% Energy & Transportation254 +0.1% Industrial Applications and Services256 0.0% Real Estate & Construction206 0.0%
Since the previous run

Rating changes

▲ 55▼ 59
Which companies were upgraded or downgraded is part of the paid plans.
Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account
Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-13) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.

Intratio is a company specialized in predictive and optimization algorithms. We forecast all US-listed stock prices. We provide our clients with the most advanced tools to build optimal stock portfolios.

Quantitative research output, not investment advice.

Connect
English
Français
Español
العربية
简体中文
Deutsch
日本語
한국어
Português
Русский
Türkçe
हिन्दी
Bahasa Indonesia
Italiano

2018–2026 © AI Stock Finder. All Rights Reserved.

  • Visa
  • Mastercard
  • American Express
  • PayPal